HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Hiroshi Sugimura Francis C. Nichols Mark S. Allen Stephen D. Cassivi Claude Deschamps Peter C. Pairolero Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sugimura, H. Articles by Pairolero, P. C. Search for Related Content PubMed PubMed Citation Articles by Sugimura, H. Articles by Pairolero, P. C. Related Collections Lung - cancer

Ann Thorac Surg 2007;83:409-418
© 2007 The Society of Thoracic Surgeons

---

Original Articles: General Thoracic

Survival After Recurrent Nonsmall-Cell Lung Cancer After Complete Pulmonary Resection

^a Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota
^b Division of General Thoracic Surgery, Mayo Clinic College of Medicine, Rochester, Minnesota
^c Section of Biostatistics, Mayo Clinic College of Medicine, Rochester, Minnesota

Accepted for publication August 28, 2006.

^_* Address correspondence to Dr Nichols, Division of General Thoracic Surgery, Mayo Clinic, 200 First St, SW, Rochester, MN 55905 (Email: nichols.francis{at}mayo.edu).

Presented at the Forty-first Annual Meeting of The Society of Thoracic Surgeons, Tampa, FL, Jan 24–26, 2005.

BACKGROUND: Survival characteristics of patients who have recurrent nonsmall-cell lung cancer after surgical resection are not well understood. Little objective evidence exists to justify treatment for these patients.

METHODS: We prospectively followed 1,361 consecutive patients with nonsmall-cell lung cancer who underwent complete surgical resection at our institution from January 1997 to December 2001. Only patients having recurrent cancer were included in the analysis. Multivariable Cox proportional hazards models were used to evaluate the effect of prognostic factors on postrecurrence survival.

RESULTS: Follow-up was achieved in 1,073 patients, and recurrent cancer developed in 445. Complete information was available on 390 patients for analysis. There were 262 men and 128 women. Median age at time of recurrence was 69 years. Median time from surgical resection to recurrence was 11.5 months, and median postrecurrence survival was 8.1 months. Recurrence was intrathoracic in 171 patients, extrathoracic in 172, and a combination of both in 47. Treatments after recurrence included surgery in 43 patients, chemotherapy in 59, radiation in 73, and a combination in 96. All patients who received treatment survived longer than those who received no treatment. Preoperative chemotherapy and postoperative radiotherapy for the primary lung cancer, poor Eastern Cooperative Oncology Group Performance Status, decreased disease-free interval from initial resection to recurrence, symptoms at recurrence, and certain location of recurrence significantly decreased postrecurrence survival.

CONCLUSIONS: In our experience, treatment for recurrent nonsmall-cell lung cancer significantly prolongs survival. Various treatment modalities including surgery should be considered in patients with postoperative recurrent nonsmall-cell lung cancer.

This article has been cited by other articles:

				J-J Hung, W-H Hsu, C-C Hsieh, B-S Huang, M-H Huang, J-S Liu, and Y-C Wu Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence Thorax, March 1, 2009; 64(3): 192 - 196. [Abstract] [Full Text] [PDF]

				T. Nakagawa, N. Okumura, K. Ohata, H. Igai, T. Matsuoka, and K. Kameyama Postrecurrence survival in patients with stage I non-small cell lung cancer Eur. J. Cardiothorac. Surg., September 1, 2008; 34(3): 499 - 504. [Abstract] [Full Text] [PDF]